Improving efficiency of low molecular weight radioligands for cancer therapy
Debiopharm, the Seeker for this Innocentive Challenge, is looking for novel broadly applicable approaches to reducing the renal reabsorption of low-molecular weight radioligands, in particular small-peptide radioligands or small-peptidomimetic radioligands, ...
